<DOC>
	<DOCNO>NCT02013635</DOCNO>
	<brief_summary>Cerebral venous thrombosis consider rare type stroke annual incidence 3 4 per million people . It occur generally young patient ( mean age occurrence = 40 year ) principally young female ( 75 % ) generally pregnancy oral contraceptive use situation . The onset may acute ( less 2 day ) , subacute ( 2 30 day ) chronic ( 30 day ) . The clinical presentation highly variable include patient mild headache , others focal neurological deficit dramatic syndrome coma . Moreover evolution different unpredictable outcome : often favorable low mortality rate , case bad course . The aim study evaluate correlation biological marker : thrombin generation test D-Dimers ( marker fibrin generation degradation ) type onset wide spectrum clinical presentation different mode evolution . All patient 16 year ago may include program CVT diagnosis prove magnetic resonance angiography ( MRA ) . For included patient , four blood assay : first time diagnosis begin treatment , second begin oral anticoagulant treatment . The third assay do third month time MRA . The last assay make one month end anticoagulant treatment 12th month begin disease treatment go . For sample , investigator perform thrombin generation test D-Dimers measurement .</brief_summary>
	<brief_title>Thrombin Generation Thrombus Degradation Cerebral Venous Thrombosis : Clinical Radiological Correlations</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Patients 16 year old hospitalize acute cerebral venous thrombosis , confirm cerebral imaging</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cerebral venous thrombosis</keyword>
	<keyword>thrombin generation</keyword>
	<keyword>d-dimers</keyword>
	<keyword>clinical evolution</keyword>
</DOC>